136 DOB
Abuse factors.Not enough scientific information to report.
Drug interactions.Alcoholmay increase the strength of a DOB dose.
Cancer.Not enough scientific information to report.
Pregnancy.Not enough scientific information to report.
Additional scientific information may be found in:
Buhrich, N., G. Morris, and G. Cook. “Bromo-DMA: The Australasian Hallucinogen?”
Australian and New Zealand Journal of Psychiatry17 (1983): 275–79.
Davis, W.M. “LSD or DOB?”American Journal of Psychiatry139 (1982): 1649.
Delliou, D. “4-Bromo-2,5-Dimethoxyamphetamine: Psychoactivity, Toxic Effects and
Analytical Methods.”Forensic Science International21 (1983): 259–67.
Shulgin, A.T., T. Sargent, and C. Naranjo. “4-Bromo-2,5-Dimethoxyphenylisopropylam-
ine, a New Centrally Active Amphetamine Analog.”Pharmacology5 (1971): 103–7.
Toennes, S.W., et al. “Aufkla ̈ rung eines unklaren neurologischen Syndroms durch tox-
ikologische Untersuchungen [Explanation of an Unclear Neurological Syndrome
by Toxicologic Investigation].”Deutsche Medizinische Wochenschrift125 (2000):
900–902. (Abstract in English).
